In March 2025, the company declared new plans for any immediate-to-purchaser offering of its Wegovy weight loss drug. The company founded a new pharmacy, named NovoCare, which would cost buyers $499 per 30 days for usage of the drug, a lot less than half the expense of the drug by other pharmaceutical distribution networks.[fifty three]In October 2